Susan Desmond-Hellmann, MD, MPH, pioneering cancer researcher and biotechnology industry executive who most recently served as president of product development for the biotechnology company, Genentech, Inc., was named chancellor of UCSF on May 7, 2009 by the University of California Board of Regents and on the recommendation of UC President Mark G. Yudof, LLB. The appointment takes effect August 3, 2009. “Dr.
